HonCode

Go Back   HER2 Support Group Forums > her2group
Register Gallery FAQ Members List Calendar Today's Posts

Reply
 
Thread Tools Display Modes
Old 07-25-2006, 10:46 AM   #1
kat in the delta
Senior Member
 
Join Date: Apr 2006
Location: MS Delta in Clarksdale="Home of the Blues" (near Memphis,TN)by Misssissippi River/levee's highest pt.
Posts: 224
Thumbs down kat in the delta

Kristen (guest) : Now what was that ??? Can you explain if Her2 is or is not inherited and how one can tell ??? That lingo is a bit much for me at this pt. in time. RSVP & please give the site.
thanks, kat

Last edited by kat in the delta; 07-25-2006 at 10:48 AM.. Reason: left out info.
kat in the delta is offline   Reply With Quote
Old 07-25-2006, 01:13 PM   #2
tousled1
Senior Member
 
tousled1's Avatar
 
Join Date: Feb 2006
Location: Acworth, GA
Posts: 2,104
My understanding is that HER2 breast cancer is not hereditary. That's not to say that if there is a high incidence of HER2 breast cancer iyour family that you won't get it. I thought that the hormone dependent breast cancer was more hereditary.
__________________
Kate
Stage IIIC Diagnosed Oct 25, 2005 (age 58)
ER/PR-, HER2+++, grade 3, Ploidy/DNA index: Aneuploid/1.61, S-phase: 24.2%
Neoadjunct chemo: 4 A/C; 4 Taxatore
Bilateral mastectomy June 8, 2006
14 of 26 nodes positive
Herceptin June 22, 2006 - April 20, 2007
Radiation (X35) July 24-September 11, 2006
BRCA1/BRCA2 negative
Stage IV lung mets July 13, 2007 - TCH
Single brain met - August 6, 2007 -CyberKnife
Oct 2007 - clear brain MRI and lung mets shrinking.
March 2008 lung met progression, brain still clear - begin Tykerb/Xeloda/Ixempra
tousled1 is offline   Reply With Quote
Old 07-25-2006, 01:51 PM   #3
penelope
Senior Member
 
Join Date: Jun 2006
Posts: 153
Ok this is what I have come to understand through my own research and the help of my sister who is a hematologist. She studies blood but is quite knowledgable in genetics.

Brca 1 and 2 are different. BRCA1 is usually estrogen negative
BRCA 2 is usually estrogen positive. This is not to say "always" but more often then not. It is unual to be BRCA1 or 2 and Her2+ as well. Again, sometimes it happens but rarely.
Her2+ is NOT genetic. I researched this at length with my sister as I am the third generation to have BC. So naturally we were worried when I was first diagnosed. I do not have any studies to cite here but I have read it several times. Now I probably carry a genetic predisposition to BC...clearly I am the third generation, but the her2+ apparently was sparodic.
__________________

penelope is offline   Reply With Quote
Old 12-07-2006, 10:54 AM   #4
Lani
Senior Member
 
Join Date: Mar 2006
Posts: 4,780
Refreshing this thread--is there such a thing as familial her2+ breast cancer?

Since 1 in 9 women are at risk for breast cancer and since BRCA1/2 make up a tiny percentage of those with breast cancer(and usually ER- AND 97% Her2---the latter for brca1 at least), the chance of two or three female relatives with breast cancer in one's family is 1 in 84 and 1 in 831. Since her2 testing has only been done regularly within the last decade and only well in most locations within the last 3 years or so (and that is only if you lived in certain developed countries and near higher powered medical centers--ie, they are still debating in France whether to routinely test new breast cancer specimens for her2 and I am entirely unsure if they are doing it in Denmark), who is to say if your relative had her2+ vs her2- breast cancer if it was diagnosed in the past or in a location unlikely to have good testing.

According to Dr. Slamon, her2 breast cancer tends to recur somewhat earlier than her2- breast cancer(but as we all know this is very variable), but more importantly perhaps for differentiating it from her2 - breast cancer, and has been (before herceptin) associated with death within an average of one year from recurrence (vs death within an average of two years from recurrence for her2- breast cancer ) {recurrence defined as distal metastasis, not lymph node metastasis or in breast recurrence}

That said, I have been researching whether therre is such a thing as her2+ breast cancer--and have found a couple of interesting articles.


Department of Radiation Oncology, Mount Sinai Medical Center, New York, NY 10029, USA.
BACKGROUND: The HER2 gene, located on the long arm of chromosome 17, codes for a protein with the characteristics of a growth factor receptor. In a preliminary study, we reported that high levels of tumor HER2 (erbB-2/neu) protein are associated with a family history of breast cancer (that is, one or more female blood relatives with breast cancer). METHODS: We have now collected a larger number of subjects (94) and performed a multivariate analysis of the independent variables family history of breast cancer, tumor estrogen receptor, age, and tumor DNA index. Family history of breast cancer was assessed by questioning the patient, in many cases by telephone. RESULTS: HER2 levels were significantly higher in women with a family history of breast cancer (p = 0.015, two-tailed t-test). The 27 women with family history were predominantly postmenopausal, mean age 61 +/- 2.3 (mean +/- SEM), versus a mean age of 56
Lani is offline   Reply With Quote
Old 12-07-2006, 10:57 AM   #5
Lani
Senior Member
 
Join Date: Mar 2006
Posts: 4,780
familial her2+ breast cancer?continued

+/- 1.7 for the 67 women with no family history. Of the 27 women with a family history of breast cancer, 13 had a first-degree relative (mother or sister) with the disease. The remaining 14 women had other relatives (grandmothers, aunts, cousins, or a niece) with breast cancer. The results of multiple linear regression analysis, with HER2 as the dependent variable, showed that family history of breast cancer was significantly associated with elevated HER2 levels in the tumors (p = 0.0038), after controlling for the effects of age, tumor estrogen receptor, and DNA index. CONCLUSIONS: The association of family history of breast cancer and elevated tumor HER2 protein suggests that postmenopausal familial breast cancer may be associated with altered HER2 expression.

This is in contrast to BRCA 1/2 breast cancer which is a premenopausal disease on the whole.

Could everyone with one or more relative (mother, daughter, sister, grandmother, aunt, etc) please post how many relatives you have with breast cancer and, as best you know, what age they were (at least what decade they were in, or pre or post menopausal)when they got it, how they are/were related to you, whether they are living or dead, whether they died of the disease (or something else), how they were treated (eg. whether surgery, whether radiation therapy, whether chemo, whether antihormonals, whether oophorectomy--ovary removal--, whether herceptin), if they were her2 tested (and as best as you can find out what the results were and whether by IHC or FISH), and, if they died, how long it was between diagnosis and death (as well as whether they were diagnosed with or without metastases and their staging(TNM) if known. T stands for size of tumor and gets a 4 if they were diagnosed with metastases, N is the number of positive lymph nodes, and M is the number of distal mets. Also if you or they were ER+ and/or PR+

This does not seem to be a sexy area for the medical researchers, but I would guess, is a concern for each and every one of you.

Will try to start a roll-call, as I am certain this board holds a treasure-trove of information which might spark the interest of some researcher to settle this question more definitively.
Lani is offline   Reply With Quote
Old 12-07-2006, 11:37 AM   #6
tousled1
Senior Member
 
tousled1's Avatar
 
Join Date: Feb 2006
Location: Acworth, GA
Posts: 2,104
Lani,

I have a very strong history of breast cancer on both mother and father's side and ovarian cancer on father's side. Due to my family history, my oncologist suggested genetic testing. I had the genetic testing performed and was really surprised that I tested negative for both BRCA1 and 2. My sister also had breast cancer but she was fortunate that her's was HER2 negative.
__________________
Kate
Stage IIIC Diagnosed Oct 25, 2005 (age 58)
ER/PR-, HER2+++, grade 3, Ploidy/DNA index: Aneuploid/1.61, S-phase: 24.2%
Neoadjunct chemo: 4 A/C; 4 Taxatore
Bilateral mastectomy June 8, 2006
14 of 26 nodes positive
Herceptin June 22, 2006 - April 20, 2007
Radiation (X35) July 24-September 11, 2006
BRCA1/BRCA2 negative
Stage IV lung mets July 13, 2007 - TCH
Single brain met - August 6, 2007 -CyberKnife
Oct 2007 - clear brain MRI and lung mets shrinking.
March 2008 lung met progression, brain still clear - begin Tykerb/Xeloda/Ixempra
tousled1 is offline   Reply With Quote
Old 12-07-2006, 11:50 AM   #7
Lani
Senior Member
 
Join Date: Mar 2006
Posts: 4,780
the best article I have found so far on this...

Am J Clin Pathol. 2003 Dec;120(6):917-27. Links
Her-2/neu gene amplification in familial vs sporadic breast cancer. Impact on the behavior of the disease.

Espinosa AB, et al
Cancer Research Center, Department of Medicine, General Cytometry Service, University of Salamanca, Salamanca, Spain.
We compared the incidence of Her-2/neu amplification in patients with and without a family history of breast cancer and correlated gene status with clinicobiologic and prognostic features in sporadic and familial cases. Of 108 patients, 28.7% had gene amplification. Among 96 cases with family history information available, 28 had an affected first-degree relative. The gene was amplified more frequently in familial than in sporadic cases (13/28 [46%] vs 14/68 [21%]; P = .01). Among familial cases, amplification was associated with adverse clinicobiologic features (poorly differentiated tumors [P = .05], larger tumors [P = .05], more lymph nodes involved [P = .04], and DNA aneuploid [P = .02] and highly proliferative tumors [P = .005]), and the relapse (P = .02) and disease-related death (P = .05) rates were higher than in cases without amplification. Among sporadic cases, amplification was not associated with significantly different disease features, except for a higher incidence of DNA aneuploid tumors (P = .01), percentage of S-phase tumor cells (P = .006), and lower proportion of estrogen (P = .001) and progesterone (P = .002) receptors. Her-2/neu amplification was observed more frequently among patients with a family history of breast cancer, in whom it was associated with adverse clinicobiologic features and a worse clinical outcome.
^^^^^^^^^
They discussed that those with sporadic (non-familial) breast cancer had a much better prognosis than those with familial (defined just as having a relative with breast cancer, since going back and testing those specimens seems to be impossible)
Lani is offline   Reply With Quote
Old 12-07-2006, 12:05 PM   #8
Jean
Senior Member
 
Join Date: Oct 2005
Location: New Jersey
Posts: 3,154
bc history

No history of breast cancer in my family I am the first.
My mother had seven sisters none of whom had breast cancer or cancer of any kind.
My mother and her sisters all lived into their 80's.
My mother died of lung cancer (she was a heavy smoker) at age 84.
All her sisters died of old age.

I have two sisters who are older than me and so far (thank God) are
healthy.

On my father's side of the family there is only one sister who is 93 yrs.
old she smokes,drinks, and lives a full life. No cancer of any kind.

My Great Grandmother lived until 102 and died of old age.
My Grandmother lived until 98 yr. old and ran her home until the day she died.
My Father's mother died during the Spannish Flu.

So, my family history was solid and boy was I surprised to be told
I had bc.

Jean
Jean is offline   Reply With Quote
Reply


Posting Rules
You may not post new threads
You may not post replies
You may not post attachments
You may not edit your posts

BB code is On
Smilies are On
[IMG] code is On
HTML code is Off

Forum Jump


All times are GMT -7. The time now is 07:16 PM.


Powered by vBulletin® Version 3.8.7
Copyright ©2000 - 2025, vBulletin Solutions, Inc.
Copyright HER2 Support Group 2007 - 2021
free webpage hit counter